Aspire Biopharma Holdings, Inc. (ASBP)
ASBP Stock Price Chart
Explore Aspire Biopharma Holdings, Inc. interactive price chart. Choose custom timeframes to analyze ASBP price movements and trends.
ASBP Company Profile
Discover essential business fundamentals and corporate details for Aspire Biopharma Holdings, Inc. (ASBP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Feb 2025
Employees
2.00
Website
https://aspirebiolabs.comCEO
Kraig T. Higginson
Description
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
ASBP Financial Timeline
Browse a chronological timeline of Aspire Biopharma Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 May 2026
EPS came in at -$20.57 , while revenue for the quarter reached $28.35k .
Stock split effective on 11 May 2026
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Mar 2026
EPS came in at -$3.15 , while revenue for the quarter reached $4.26k .
Stock split effective on 16 Jan 2026
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2025
EPS came in at -$0.04 , while revenue for the quarter reached $1.94k .
Earnings released on 13 Aug 2025
EPS came in at -$0.04 .
Earnings released on 14 May 2025
EPS came in at -$16.80 .
Earnings released on 7 Apr 2025
EPS came in at -$0.28 .
Earnings released on 14 Nov 2024
EPS came in at -$0.02 .
Earnings released on 16 Aug 2024
EPS came in at -$0.02 .
Earnings released on 5 Jun 2024
EPS came in at -$0.07 .
Earnings released on 11 Mar 2024
EPS came in at -$0.00 .
Earnings released on 7 Nov 2023
EPS came in at -$0.00 .
Earnings released on 8 Aug 2023
EPS came in at $0.01 .
Earnings released on 11 May 2023
EPS came in at $0.02 .
Earnings released on 21 Mar 2023
EPS came in at $0.02 .
Earnings released on 10 Nov 2022
EPS came in at $0.01 .
Earnings released on 11 Aug 2022
EPS came in at $0.00 .
Earnings released on 16 May 2022
EPS came in at -$0.00 .
Earnings released on 31 Dec 2021
EPS came in at -$0.00 .
Earnings released on 30 Sept 2021
EPS came in at -$0.00 .
ASBP Stock Performance
Access detailed ASBP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
